Share This Article:

Primary CNS Marginal Zone Lymphoma: A Case Report and Review of the Literature

Abstract Full-Text HTML Download Download as PDF (Size:876KB) PP. 55-59
DOI: 10.4236/ojpathology.2013.32010    3,962 Downloads   6,305 Views   Citations

ABSTRACT

Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma (NHL) located in the craniospinal axis (affecting CNS, meninges and eye) without evidence of a systemic primary tumor. CNS lymphomas are typically high grade, large cell lymphomas; low grade CNS lymphomas are rare. We encountered a case of 48-year old patient with recurrent episodes of seizures, weakness of bilateral extremities and memory loss. On MRI and CT scan, a 2.0 cm area of ill-defined enhancement with associated edema was present in the left frontal subcortex. The biopsy revealed an infiltrate of small lymphocytes expressing pan B-cell markers and an immunoprofile consistent with an extranodal marginal zone B cell lymphomas of mucosa associated lymphoid tissue (MALT). Clonal rearrangement was demonstrated by PCR analysis. Subsequently, the patient was treated with radiation therapy and responded well, with decrease in the size of the lesion. He is alive and well for 1 year and 3 months up to the date of this report.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

B. Aqil, E. Rouah and G. Verstovsek, "Primary CNS Marginal Zone Lymphoma: A Case Report and Review of the Literature," Open Journal of Pathology, Vol. 3 No. 2, 2013, pp. 55-59. doi: 10.4236/ojpathology.2013.32010.

References

[1] D. Raoux, S. Duband, F. Forest, B. Trombert, M. L. Chambonnière, J. Dumollard, A. Khaddage, A. Gentil-Perret and M. Péoch, “Primary Central Nervous System Lymphoma: Immunohistochemical Profile and Prognostic Significance,” Neuropathology, Vol. 30, No. 3, 2010, pp. 232-240.
[2] D. L. Commins, “Pathology of Primary Central Nervous System Lymphoma,” Neurosurgical Focus, Vol. 21, No. 5, 2006, pp. E2.
[3] N. P. Mendenhall, T. L. Thar, O. F. Agee, et al., “Primary Lymphoma of the Central Nervous System. Computerized Tomography Scan Characteristics and Treatment Results for 12 Cases,” Cancer, Vol. 52, No. 1983, pp. 1993-2000. doi:10.1002/1097-0142(19831201) 52:11<1993::AID-CNCR2820521104>3.0.CO;2-C
[4] N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini and K. C. Gatter, “A Revised Europe and American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group,” Blood, Vol. 84, No. 5, 1994, pp. 1361-1392.
[5] P. Isaacson and D. H. Wright, “Malignant Lymphoma of Mucosa-Associated Lymphoid Tissue. A Distinctive Type of B-Cell Lymphoma,” Cancer, Vol. 52, 1983, pp. 1410-1416. doi:10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3
[6] S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele and J. W. Vardiman, “WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues,” 4th Edition, IARC Press, Lyon, 2008.
[7] P. H. Tu, C. Giannini, A. R. Judkins, J. M. Schwalb, R. Burack, B. P. O’Neill, A. T. Yachnis, P. C. Burger, B. W. Scheithauer and A. Perry, “Clinicopathologic and Genetic Profile of Intracranial Marginal Zone Lymphoma: A Primary Low-Grade CNS Lymphoma That Mimics Meningioma,” Journal of Clinical Oncology, Vol. 23, No. 24, 2005, pp. 5718-5727. doi:10.1200/JCO.2005.17.624
[8] T. Itoh, M. Shimizu, K. Kitami, K. Kamata, K. Mitsumori, M. Fujita, A. Ohnishi and K. Nagashima, “Primary Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type in the CNS,” Neuropathology, Vol. 21, No. 3, 2001, pp. 174-180. doi:10.1046/j.1440-1789.2001.00392.x
[9] I. Park, J. Huh, J. H. Kim, S. W. Lee, M. H. Ryu and Y. K. Kang, “Primary Central Nervous System Marginal Zone B-Cell Lymphoma of the Basal Ganglia Mimicking Low-Grade Glioma: A Case Report and Review of the Literature,” Clinical Lymphoma Myeloma, Vol. 8, No. 5, 2008, pp. 305-308. doi:10.3816/CLM.2008.n.043
[10] A. Papanicolau-Sengo, J. Wang-Rodriguez, W. Huan-You, R. Lee, A. Wong, L. A. Hansen, S. Sepi Mahooti and H. H. Rashidi, “Rare Case of a Primary Non-Dural Central Nervous System Low Grade B-Cell Lymphoma and Literature Review,” International Journal of Clinical and Experimental Pathology, Vol. 5, No. 1, 2012, pp. 89-95.
[11] G. N. Fuller and J. C. Goodman, “Practical Review of Neuropathology,” Lippincott, Williams & Wilkins, Philadelphia, 2001, pp. 57-58.
[12] S. Kumar, D. Kumar, E. P. Kaldjian, et al., “Primary Low-Grade B-Cell Lymphoma of the Dura: A Mucosa Associated Lymphoid Tissue-Type Lymphoma,” The American Journal of Surgical Pathology, Vol. 21, No. 1, 1997, pp. 81-87. doi:10.1097/00000478-199701000-00009
[13] A. C. Wotherspoon, C. Doglioni, T. C. Diss, et al., “Regression of Primary Low Grade B-Cell Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type after Eradication of Helicobacter Pylori,” Lancet, Vol. 342, 1993, pp. 575-577. doi:10.1016/0140-6736(93)91409-F
[14] M. Lecuit, E. Abachin, A. Martin, et al., “Immunoproliferative Small Intestinal Disease Associated with Campylobacter Jejuni,” The New England Journal of Medicine, Vol. 350, No. 8871, 2004, pp. 239-248. doi:10.1056/NEJMoa031887
[15] A. J. Ferreri, M. Ponzoni, M. Guidoboni, et al., “Bacteria-Eradicating Therapy with Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial,” Journal of the National Cancer Institute, Vol. 98, No. 19, 2006, pp. 1375-1382. doi:10.1093/jnci/djj373
[16] C. Garbe, H. Stein, D. Dienemann, et al., “Borrelia Burgdorferi-Associated Cutaneous B Cell Lymphoma: Clinical and Immunohistologic Characterization of Four Cases,” Journal of the American Academy of Dermatology, Vol. 24, No. 4, 1991, pp. 584-590. doi:10.1016/0190-9622(91)70088-J
[17] K. Lewis, C. Vandervelde, R. Grace, et al., “Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma in 2 Patients with Sjogren’s Syndrome: Clinical and Sonographic Features with Pathological Correlation,” Journal of Clinical Ultrasound, Vol. 35, No. 2, 2007, pp. 97-101. doi:10.1002/jcu.20280
[18] R. Wozniak, L. Beckwith, H. Ratech, et al., “Maltoma of the Thyroid in a Man with Hashimoto’s Thyroiditis,” The Journal of Clinical Endocrinology & Metabolism, Vol. 84, No. 4, 1999, pp. 1206-1209. doi:10.1210/jc.84.4.1206
[19] A. Sanjeevi, J. Krishnan, P. R. Bailey, et al., “Extranodal Marginal Zone B-Cell Lymphoma of Malt Type Involving the Cavernous Sinus,” Leukemia & Lymphoma, Vol. 42, No. 5, 2001, pp. 1133-1137. doi:10.3109/10428190109097736
[20] T. Akagi, M. Motegi, A. Tamura, et al., “A Novel Gene, MALT1 at 18q21, Is Involved in t(11;18)(q21;q21) Found in Low Grade B-Cell Ymphoma of Mucosa Associated Lymphoid Tissue,” Oncogene, Vol. 18, No. 42, 1999, pp. 5785-5794. doi:10.1038/sj.onc.1203018
[21] B. Maes and C. de Wolf-Peeters, “Marginal Zone B Cell Lymphoma: An Update on Recent Advances,” Histopathology, Vol. 40, No. S3, 2002, pp. 117-126. doi:10.1046/j.1365-2559.2002.01360.x
[22] L. Pasqualucci, O. Bereschenko, H. Niu, et al., “Molecular Pathogenesis of Non-Hodgkin’s Lymphoma: The Role of Bcl-6,” Leukemia & Lymphoma, Vol. 44, No. S3, 2003, pp. S5-S12. doi:10.1080/10428190310001621588
[23] J. Dierlamm, S. Pittaluga, M. Stul, et al., “BCL6 Gene Rearrangements Also Occur in Marginal Zone B-Cell Lymphoma,” British Journal of Haematology, Vol. 98, No. 3, 1997, pp. 719-725. doi:10.1046/j.1365-2141.1997.2703087.x
[24] N. Kambham, Y. Chang and A. Y. Matsushima, “Primary Lowgrade B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Arising in Dura,” Clinical Neuropathology, Vol. 17, 1998, pp. 311-317.
[25] M. Estevez, C. Chu, M. Pless, “ Small B-cell lym-phoma presenting as diffuse dural thickening with cranial neuropathies,” Journal of Neuro-Oncology, Vol. 59, No. 3, 2002, pp. 243-237. doi:10.1023/A:1019913611512
[26] A. Garcia-Serra, M. N. Price, R. W. Hinerman, et al., “Management of Neurotropic Low-Grade B-Cell Lymphoma: Report of Two Cases,” Head & Neck, Vol. 25, No. 11, 2003, pp. 972-976. doi:10.1002/hed.10311
[27] N. L. Lehman, D. S. Horoupian, R. A. Warnke, et al., “Dural Marginal Zone Lymphoma with Massive Amyloid Deposition: Rare Low-Grade Primary Central Nervous System B-Cell Lymphoma. Case Report,” Journal of Neurosurgery, Vol. 96, No. 2, 2002, pp. 368-372. doi:10.3171/jns.2002.96.2.0368
[28] W. Razaq, A. Goel, A. Amin and M. L. Grossbard, “Primary Central Nervous System Mucosa-Associated Lymphoid Tissue Lymphoma: Report and Literature Review,” Clinical Lymphoma Myeloma and Leukemia, Vol. 9, No. 3, 2009, pp. E5-E9. doi:10.3816/CLM.2009.n.052

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.